T1	PROC 47 61	ensayo clínico
#1	AnnotatorNotes T1	C0008976; Clinical Trials; Research Activity
T2	DISO 79 110	cáncer de pulmón no microcítico
#2	AnnotatorNotes T2	C0007131; Non-Small Cell Lung Carcinoma; Neoplastic Process
T3	PROC 136 147	tratamiento
#3	AnnotatorNotes T3	C0087111; Therapeutic procedure; Therapeutic or Preventive Procedure
T4	CHEM 227 252	fármacos en investigación
#4	AnnotatorNotes T4	C0013230; Investigational New Drugs; Pharmacologic Substance
T5	CHEM 253 261	MEDI4736
#5	AnnotatorNotes T5	C3641122; MEDI4736; Amino Acid, Peptide, or Protein · Immunologic Factor · Pharmacologic Substance
T6	CHEM 263 273	durvalumab
#6	AnnotatorNotes T6	C4055109; durvalumab; Amino Acid, Peptide, or Protein · Immunologic Factor · Pharmacologic Substance
T7	CHEM 277 289	tremelimumab
#7	AnnotatorNotes T7	C2351038; tremelimumab; Amino Acid, Peptide, or Protein · Immunologic Factor · Pharmacologic Substance
T8	CHEM 377 385	MEDI4736
#8	AnnotatorNotes T8	C3641122; MEDI4736; Amino Acid, Peptide, or Protein · Immunologic Factor · Pharmacologic Substance
T9	CHEM 330 338	fármacos
#9	AnnotatorNotes T9	C0013227; Pharmaceutical Preparations; Pharmacologic Substance | C0456386; Medicament; Pharmacologic Substance
T10	CHEM 363 369	agente
#10	AnnotatorNotes T10	C0450442; Agent; Chemical Viewed Functionally
T11	PROC 389 400	monoterapia
#11	AnnotatorNotes T11	C4763675; Single Agent Therapy; Therapeutic or Preventive Procedure
T12	PROC 424 431	terapia
#12	AnnotatorNotes T12	C0087111; Therapeutic procedure; Therapeutic or Preventive Procedure
T13	CHEM 459 471	tremelimumab
#13	AnnotatorNotes T13	C2351038; tremelimumab; Amino Acid, Peptide, or Protein · Immunologic Factor · Pharmacologic Substance
T14	PROC 494 520	Estudio abierto de Fase 1b
T15	PROC 526 562	evaluar la seguridad y tolerabilidad
T16	CHEM 594 606	Tremelimumab
#14	AnnotatorNotes T16	C2351038; tremelimumab; Amino Acid, Peptide, or Protein · Immunologic Factor · Pharmacologic Substance
T17	DISO 624 655	cáncer de pulmón no microcítico
#15	AnnotatorNotes T17	C0007131; Non-Small Cell Lung Carcinoma; Neoplastic Process
T18	DISO 686 714	Cáncer Pulmón no microcítico
T19	DISO 818 836	Cáncer metastásico
T20	CHEM 566 574	MEDI4736
#16	AnnotatorNotes T20	C3641122; MEDI4736; Amino Acid, Peptide, or Protein · Immunologic Factor · Pharmacologic Substance
T21	DISO 731 747	cáncer de pulmón
#17	AnnotatorNotes T21	C0242379; Malignant neoplasm of lung; Neoplastic Process | C0684249; Carcinoma of lung; Neoplastic Process
T22	ANAT 767 775	escamoso
#18	AnnotatorNotes T22	C0221909; Squamous epithelium; Tissue
T23	ANAT 779 787	escamoso
#19	AnnotatorNotes T23	C0221909; Squamous epithelium; Tissue
T24	ANAT 798 805	células
#20	AnnotatorNotes T24	C0007634; Cells; Cell | C1269647; Entire cell; Cell
T25	ANAT 693 699	Pulmón
#21	AnnotatorNotes T25	C0024109; Lung; Body Part, Organ, or Organ Component | C1278908; Entire lung; Body Part, Organ, or Organ Component
T26	DISO 912 979	Cáncer de Pulmón no microcítico escamoso o no escamoso, metastásico
T27	ANAT 944 952	escamoso
#22	AnnotatorNotes T27	C0221909; Squamous epithelium; Tissue
T28	ANAT 958 966	escamoso
#23	AnnotatorNotes T28	C0221909; Squamous epithelium; Tissue
T29	DISO 1003 1007	CPNM
#24	AnnotatorNotes T29	C0007131; Non-Small Cell Lung Carcinoma; Neoplastic Process
T30	DISO 1069 1085	CPNM metastásico
T31	CHEM 433 441	MEDI4736
#25	AnnotatorNotes T31	C3641122; MEDI4736; Amino Acid, Peptide, or Protein · Immunologic Factor · Pharmacologic Substance
T32	ANAT 1137 1145	escamoso
#26	AnnotatorNotes T32	C0221909; Squamous epithelium; Tissue
T33	ANAT 1151 1159	escamoso
#27	AnnotatorNotes T33	C0221909; Squamous epithelium; Tissue
T34	DISO 1250 1267	lesión mensurable
T35	DISO 1301 1307	lesión
#28	AnnotatorNotes T35	C0221198; Lesion; Finding
T36	PROC 1318 1325	biopsia
#29	AnnotatorNotes T36	C0005558; Biopsy; Diagnostic Procedure
T37	ANAT 1396 1407	médula ósea
#30	AnnotatorNotes T37	C0005953; Bone Marrow; Tissue
T38	PROC 1457 1470	quimioterapia
#31	AnnotatorNotes T38	C0392920; Chemotherapy Regimen; Therapeutic or Preventive Procedure | C3665472; Chemotherapy; Therapeutic or Preventive Procedure
T39	PROC 1472 1485	inmunoterapia
#32	AnnotatorNotes T39	C0021083; Immunotherapy; Therapeutic or Preventive Procedure
T40	PROC 1487 1515	terapia biológica u hormonal
T41	CHEM 1507 1515	hormonal
#33	AnnotatorNotes T41	C0019932; Hormones; Hormone
T42	PROC 1537 1559	tratamiento del cáncer
#34	AnnotatorNotes T42	C0920425; cancer treatment; Therapeutic or Preventive Procedure
T43	CHEM 1586 1615	medicamentos inmunosupresores
T44	CHEM 1684 1694	medicación
#35	AnnotatorNotes T44	C0013227; Pharmaceutical Preparations; Pharmacologic Substance | C0456386; Medicament; Pharmacologic Substance
T45	ANAT 703 714	microcítico
#36	AnnotatorNotes T45	C1514085; Neoplastic Small Cell; Cell | C1518241; Malignant Small Cell; Cell
T46	DISO 1710 1737	Trastornos autoinmunitarios
T47	PROC 1799 1812	Cirugía mayor
#37	AnnotatorNotes T47	C0679637; major surgery; Therapeutic or Preventive Procedure
T48	CHEM 1887 1897	medicación
#38	AnnotatorNotes T48	C0013227; Pharmaceutical Preparations; Pharmacologic Substance | C0456386; Medicament; Pharmacologic Substance
T49	ANAT 89 95	pulmón
#39	AnnotatorNotes T49	C0024109; Lung; Body Part, Organ, or Organ Component | C1278908; Entire lung; Body Part, Organ, or Organ Component
T50	ANAT 99 110	microcítico
#40	AnnotatorNotes T50	C1514085; Neoplastic Small Cell; Cell | C1518241; Malignant Small Cell; Cell
T51	PROC 161 199	investigar la seguridad, tolerabilidad
T52	ANAT 634 640	pulmón
#41	AnnotatorNotes T52	C0024109; Lung; Body Part, Organ, or Organ Component | C1278908; Entire lung; Body Part, Organ, or Organ Component
T53	ANAT 644 655	microcítico
#42	AnnotatorNotes T53	C1514085; Neoplastic Small Cell; Cell | C1518241; Malignant Small Cell; Cell
T54	ANAT 741 747	pulmón
#43	AnnotatorNotes T54	C0024109; Lung; Body Part, Organ, or Organ Component | C1278908; Entire lung; Body Part, Organ, or Organ Component
T55	ANAT 922 928	Pulmón
#44	AnnotatorNotes T55	C0024109; Lung; Body Part, Organ, or Organ Component | C1278908; Entire lung; Body Part, Organ, or Organ Component
T56	ANAT 932 943	microcítico
#45	AnnotatorNotes T56	C1514085; Neoplastic Small Cell; Cell | C1518241; Malignant Small Cell; Cell
T57	DISO 1553 1559	cáncer
#46	AnnotatorNotes T57	C0006826; Malignant Neoplasms; Neoplastic Process
T58	PROC 1652 1666	administración
#47	AnnotatorNotes T58	C1533734; Administration procedure; Therapeutic or Preventive Procedure
T59	PROC 1849 1863	administración
#48	AnnotatorNotes T59	C1533734; Administration procedure; Therapeutic or Preventive Procedure
T60	Date 12 16	2015
T61	LIVB 65 74	pacientes
#49	AnnotatorNotes T61	C0030705; Patients; Patient or Disabled Group
T62	Neg_cue 96 98	no
T64	LIVB 610 619	pacientes
#50	AnnotatorNotes T64	C0030705; Patients; Patient or Disabled Group
T65	Neg_cue 641 643	no
T66	Neg_cue 700 702	no
T67	Neg_cue 776 778	no
T68	Neg_cue 929 931	no
T69	Neg_cue 955 957	no
T70	Age 1043 1053	> =18 años
T71	Neg_cue 1148 1150	no
T73	Date 1576 1582	actual
T74	Duration 1624 1635	los 14 días
T75	CONC 1667 1680	primera dosis
T76	Duration 1777 1795	los últimos 2 años
T77	Duration 1821 1832	los 28 días
T78	CONC 1870 1883	primera dosis
T63	PHYS 1371 1390	funciones orgánicas
#51	AnnotatorNotes T63	C1254358; Organ or Tissue Function; Organ or Tissue Function
T72	PHYS 1371 1380;1393 1407	funciones de médula ósea
T79	PROC 1164 1180	Estado funcional
#52	AnnotatorNotes T79	C4525818; Clinical Performance Status; Health Care Activity | C3694602; functional status of patient; Therapeutic or Preventive Procedure
T80	PROC 1119 1135	histológicamente
#53	AnnotatorNotes T80	C0344441; Histology Procedure; Laboratory Procedure
A1	Assertion T50 Negated
A2	Assertion T53 Negated
A3	Assertion T45 Negated
A4	Assertion T23 Negated
A5	Assertion T56 Negated
A6	Assertion T28 Negated
A7	Assertion T33 Negated
#54	AnnotatorNotes T51	C1705187; Safety Study; Research Activity + C3274448; Tolerability Study; Research Activity
#55	AnnotatorNotes T15	C1705187; Safety Study; Research Activity + C3274448; Tolerability Study; Research Activity
#56	AnnotatorNotes T18	C0007131; Non-Small Cell Lung Carcinoma; Neoplastic Process
#57	AnnotatorNotes T19	C0027627; Neoplasm Metastasis; Neoplastic Process
#58	AnnotatorNotes T30	C0027627; Neoplasm Metastasis; Neoplastic Process + C0007131; Non-Small Cell Lung Carcinoma; Neoplastic Process
#59	AnnotatorNotes T34	C5238366; Measurable Lesion; Finding 
#60	AnnotatorNotes T43	C0021081; Immunosuppressive Agents; Immunologic Factor · Pharmacologic Substance
#61	AnnotatorNotes T73	C0521116; Current (present time); Temporal Concept 
#62	AnnotatorNotes T46	C0004364; Autoimmune Diseases; Disease or Syndrome
T81	Observation 122 147	respondido al tratamiento
A8	Assertion T81 Negated
A9	Status T3 History_of
T82	Neg_cue 115 117	no
R1	Negation Arg1:T62 Arg2:T50	
R2	Negation Arg1:T82 Arg2:T81	
R3	Negation Arg1:T65 Arg2:T53	
R4	Negation Arg1:T66 Arg2:T45	
R5	Negation Arg1:T67 Arg2:T23	
R6	Negation Arg1:T69 Arg2:T28	
R7	Negation Arg1:T68 Arg2:T56	
R8	Negation Arg1:T71 Arg2:T33	
R9	Experiences Arg1:T61 Arg2:T2	
R10	Location_of Arg1:T49 Arg2:T2	
R11	Experiences Arg1:T61 Arg2:T81	
R12	Overlap Arg1:T2 Arg2:T81	
R13	Overlap Arg1:T81 Arg2:T3	
R14	Experiences Arg1:T61 Arg2:T4	
R15	Experiences Arg1:T61 Arg2:T5	
R16	Experiences Arg1:T61 Arg2:T6	
R17	Experiences Arg1:T61 Arg2:T7	
R18	Combined_with Arg1:T5 Arg2:T7	
R19	Combined_with Arg1:T6 Arg2:T7	
T83	Observation 313 319	efecto
#63	AnnotatorNotes T83	C1518681; Outcome of Therapy; Finding (?)
R20	Causes Arg1:T9 Arg2:T83	
R21	Causes Arg1:T10 Arg2:T83	
T84	Quantifier_or_Qualifier 370 375	único
#64	AnnotatorNotes T84	C0205171; Singular; Quantitative Concept
R22	Has_Quantifier_or_Qualifier Arg1:T10 Arg2:T84	
R23	Causes Arg1:T8 Arg2:T83	
R24	Used_for Arg1:T8 Arg2:T11	
R25	Used_for Arg1:T31 Arg2:T12	
R26	Combined_with Arg1:T31 Arg2:T13	
R27	Causes Arg1:T12 Arg2:T83	
R28	Combined_with Arg1:T20 Arg2:T16	
R29	Experiences Arg1:T64 Arg2:T20	
R30	Experiences Arg1:T64 Arg2:T17	
R31	Location_of Arg1:T52 Arg2:T17	
T85	Quantifier_or_Qualifier 656 664	avanzado
#65	AnnotatorNotes T85	C0205179; Advanced phase; Qualitative Concept | C1522484; metastatic qualifier; Functional Concept
R32	Has_Quantifier_or_Qualifier Arg1:T17 Arg2:T85	
T86	Quantifier_or_Qualifier 837 856	localmente avanzado
R33	Has_Quantifier_or_Qualifier Arg1:T19 Arg2:T86	
T87	Quantifier_or_Qualifier 982 1001	localmente avanzado
T88	Quantifier_or_Qualifier 1088 1107	localmente avanzado
R35	Has_Quantifier_or_Qualifier Arg1:T30 Arg2:T88	
R37	Has_Quantifier_or_Qualifier Arg1:T29 Arg2:T87	
R38	Location_of Arg1:T25 Arg2:T18	
R39	Location_of Arg1:T54 Arg2:T21	
R40	Location_of Arg1:T22 Arg2:T21	
R41	Location_of Arg1:T23 Arg2:T21	
R43	Location_of Arg1:T32 Arg2:T30	
R44	Location_of Arg1:T33 Arg2:T30	
T89	CONC 1185 1219	Eastern Cooperative Oncology Group
#66	AnnotatorNotes T89	C1520224; ECOG performance status; Intellectual Product
R45	Used_for Arg1:T89 Arg2:T79	
T90	CONC 1221 1225	ECOG
#67	AnnotatorNotes T90	C1520224; ECOG performance status; Intellectual Product
R46	Used_for Arg1:T90 Arg2:T79	
T91	Result_or_Value 1230 1235	0 o 1
R47	Has_Result_or_Value Arg1:T89 Arg2:T91	
R48	Has_Result_or_Value Arg1:T90 Arg2:T91	
T92	Quantifier_or_Qualifier 1239 1249	Al menos 1
R49	Has_Quantifier_or_Qualifier Arg1:T34 Arg2:T92	
T93	Quantifier_or_Qualifier 1290 1300	Al menos 1
R50	Has_Quantifier_or_Qualifier Arg1:T35 Arg2:T93	
T94	CONC 1274 1285	RECIST v1.1
#68	AnnotatorNotes T94	C1709926; Response Evaluation Criteria in Solid Tumors; Intellectual Product
T95	PROC 1337 1346	selección
#69	AnnotatorNotes T95	C0242802; Patient Selection; Research Activity
R52	Overlap Arg1:T36 Arg2:T95	
R53	Overlap Arg1:T35 Arg2:T95	
R54	Location_of Arg1:T37 Arg2:T72	
T96	Observation 1371 1417	funciones orgánicas y de médula ósea adecuadas
R55	Used_for Arg1:T41 Arg2:T40	
T97	Quantifier_or_Qualifier 1516 1528	concomitante
#70	AnnotatorNotes T97	C0521115; Simultaneous; Temporal Concept
R56	Has_Quantifier_or_Qualifier Arg1:T40 Arg2:T97	
#71	AnnotatorNotes T40	C0005527; Biological Response Modifier Therapy; Therapeutic or Preventive Procedure | C0279025; Hormone Therapy; Therapeutic or Preventive Procedure
R57	Has_Quantifier_or_Qualifier Arg1:T38 Arg2:T97	
R58	Has_Quantifier_or_Qualifier Arg1:T39 Arg2:T97	
R59	Overlap Arg1:T43 Arg2:T73	
A10	Status T43 History_of
R60	Has_Duration_or_Interval Arg1:T43 Arg2:T74	
R61	Before Arg1:T43 Arg2:T58	
R62	Used_for Arg1:T44 Arg2:T58	
R63	Has_Dose_or_Strength Arg1:T44 Arg2:T75	
A11	Status T46 History_of
R64	Has_Duration_or_Interval Arg1:T46 Arg2:T76	
T98	Quantifier_or_Qualifier 1738 1745	activos
A12	Status T98 History_of
#72	AnnotatorNotes T98	C0205177; Active; Qualitative Concept | C0679217; Active State; Idea or Concept
R65	Has_Quantifier_or_Qualifier Arg1:T46 Arg2:T98	
R66	Overlap Arg1:T47 Arg2:T77	
R67	Before Arg1:T47 Arg2:T59	
R68	Used_for Arg1:T48 Arg2:T59	
R69	Has_Dose_or_Strength Arg1:T48 Arg2:T78	
R70	Location_of Arg1:T53 Arg2:T17	
R71	Location_of Arg1:T45 Arg2:T18	
R72	Location_of Arg1:T50 Arg2:T2	
R73	Location_of Arg1:T56 Arg2:T26	
R74	Location_of Arg1:T27 Arg2:T26	
R75	Location_of Arg1:T28 Arg2:T26	
R76	Location_of Arg1:T55 Arg2:T26	
R77	Location_of Arg1:T55 Arg2:T29	
R78	Location_of Arg1:T56 Arg2:T29	
R79	Experiences Arg1:T61 Arg2:T3	
R34	Has_Quantifier_or_Qualifier Arg1:T26 Arg2:T87	
#73	AnnotatorNotes R69	(?)
#74	AnnotatorNotes T78	C5236155; Date of First Dose; Temporal Concept
#75	AnnotatorNotes R63	(?)
#76	AnnotatorNotes T75	C5236155; Date of First Dose; Temporal Concept
#77	AnnotatorNotes T26	C4763570; Metastatic Lung Non-Small Cell Squamous Carcinoma; Neoplastic Process (?) | C4288755; Metastatic Lung Non-Squamous Non-Small Cell Carcinoma; Neoplastic Process (?)
#78	AnnotatorNotes T81	C4522175; Response to cancer treatment; Finding
A13	Experiencer T61 Patient
A14	Experiencer T64 Patient
